# Matti Aapro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matti-aapro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,649 |
| Field | Nausea and vomiting management |
| h-index | 103 |
| i10-index | 366 |
| Last Known Institution | Clinique de Genolier |
| OpenAlex ID | https://openalex.org/A5033285318 |
| ORCID iD | https://orcid.org/0000-0003-3570-8319 |
| Works | 858 |

## Researcher papers

- [3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)](https://scholariq.org/papers/3rd-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-3/)
- [5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)](https://scholariq.org/papers/5th-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-5/)
- [4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)](https://scholariq.org/papers/4th-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-4/)
- [Integration of oncology and palliative care: a Lancet Oncology Commission](https://scholariq.org/papers/integration-of-oncology-and-palliative-care-a-lancet-oncology-commission/)
- [Delivering affordable cancer care in high-income countries](https://scholariq.org/papers/delivering-affordable-cancer-care-in-high-income-countries/)
- [Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives](https://scholariq.org/papers/digital-health-for-optimal-supportive-care-in-oncology-benefits-limits-and/)
- [進行性乳癌のためのESO-ESMO国際コンセンサスガイドライン第四版(ABC 4)](https://scholariq.org/papers/eso-esmo-abc-4/)
- [A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy](https://scholariq.org/papers/a-randomized-phase-iii-study-evaluating-the-efficacy-and-safety-of-nepa-a-fixed/)
- [6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)](https://scholariq.org/papers/6th-and-7th-international-consensus-guidelines-for-the-management-of-advanced/)

## Researcher topics

- [Nausea and vomiting management](https://scholariq.org/topics/nausea-and-vomiting-management/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Researcher university

- [Clinique de Genolier](https://scholariq.org/institutions/clinique-de-genolier/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.